These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 17674201
1. Assessing the economic burden of breast cancer in a US managed care population. Barron JJ, Quimbo R, Nikam PT, Amonkar MM. Breast Cancer Res Treat; 2008 May; 109(2):367-77. PubMed ID: 17674201 [Abstract] [Full Text] [Related]
2. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis. Pelletier EM, Shim B, Goodman S, Amonkar MM. Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662 [Abstract] [Full Text] [Related]
3. The economic burden of lung cancer and the associated costs of treatment failure in the United States. Kutikova L, Bowman L, Chang S, Long SR, Obasaju C, Crown WH. Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249 [Abstract] [Full Text] [Related]
4. Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States. Fu AZ, Jhaveri M. J Med Econ; 2012 Nov; 15(4):688-94. PubMed ID: 22397589 [Abstract] [Full Text] [Related]
5. The economic burden of metastatic breast cancer: a U.S. managed care perspective. Montero AJ, Eapen S, Gorin B, Adler P. Breast Cancer Res Treat; 2012 Jul; 134(2):815-22. PubMed ID: 22684273 [Abstract] [Full Text] [Related]
6. Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry. Baser O, Wei W, Henk HJ, Teitelbaum A, Xie L. Curr Med Res Opin; 2012 Mar; 28(3):419-28. PubMed ID: 22364568 [Abstract] [Full Text] [Related]
7. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population. Sasser AC, Rousculp MD, Birnbaum HG, Oster EF, Lufkin E, Mallet D. Womens Health Issues; 2005 Mar; 15(3):97-108. PubMed ID: 15894195 [Abstract] [Full Text] [Related]
8. Economic outcomes of breast cancer survivorship: CALGB study 79804. Hensley ML, Dowell J, Herndon JE, Winer E, Stark N, Weeks JC, Paskett E. Breast Cancer Res Treat; 2005 May; 91(2):153-61. PubMed ID: 15868443 [Abstract] [Full Text] [Related]
9. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis. Ghatnekar O, Alvegård T, Conradi N, Lenhoff S, Mellqvist UH, Persson U, Löthgren M. Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377 [Abstract] [Full Text] [Related]
10. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, Perkins GH, Elting LS. J Clin Oncol; 2009 Apr 20; 27(12):2007-14. PubMed ID: 19289624 [Abstract] [Full Text] [Related]
11. The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma. Oestreicher N, Ramsey SD, McCune JS, Linden HM, Veenstra DL. Cancer; 2005 Nov 15; 104(10):2054-62. PubMed ID: 16216002 [Abstract] [Full Text] [Related]
12. Economic burden of rhinitis in managed care: a retrospective claims data analysis. Dalal AA, Stanford R, Henry H, Borah B. Ann Allergy Asthma Immunol; 2008 Jul 15; 101(1):23-9. PubMed ID: 18681080 [Abstract] [Full Text] [Related]
13. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods. Tunceli O, Wade R, Gu T, Bouchard JR, Aagren M, Luo W. Curr Med Res Opin; 2010 Aug 15; 26(8):1827-34. PubMed ID: 20491613 [Abstract] [Full Text] [Related]
14. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA. Clin Ther; 2008 Feb 15; 30(2):358-71. PubMed ID: 18343274 [Abstract] [Full Text] [Related]
15. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population. Menzin J, Boulanger L, Marton J, Guadagno L, Dastani H, Dirani R, Phillips A, Shah H. Respir Med; 2008 Sep 15; 102(9):1248-56. PubMed ID: 18620852 [Abstract] [Full Text] [Related]
16. Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting. Ritzwoller DP, Ellis JL, Korner EJ, Hartsfield CL, Sadosky A. Curr Med Res Opin; 2009 Jun 15; 25(6):1319-28. PubMed ID: 19419344 [Abstract] [Full Text] [Related]
17. Direct costs of blindness experienced by patients enrolled in managed care. Frick KD, Walt JG, Chiang TH, Doyle JJ, Stern LS, Katz LM, Dolgitser M, Hendlish SK. Ophthalmology; 2008 Jan 15; 115(1):11-7. PubMed ID: 17475331 [Abstract] [Full Text] [Related]
18. Burden of illness of hepatitis C from a managed care organization perspective. Armstrong EP, Charland SL. Curr Med Res Opin; 2004 May 15; 20(5):671-9. PubMed ID: 15140332 [Abstract] [Full Text] [Related]
19. Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis. Duh MS, Dial E, Choueiri TK, Fournier AA, Antras L, Rodermund D, Neary MP, Oh WK. Curr Med Res Opin; 2009 Aug 15; 25(8):2081-90. PubMed ID: 19586325 [Abstract] [Full Text] [Related]
20. Comparison of health care costs and co-morbidities between men diagnosed with benign prostatic hyperplasia and cardiovascular disease (CVD) and men with CVD alone in a US commercial population. Shah M, Butler M, Bramley T, Curtice TG, Fine S. Curr Med Res Opin; 2007 Feb 15; 23(2):417-26. PubMed ID: 17288695 [Abstract] [Full Text] [Related] Page: [Next] [New Search]